Unternehmen
F. HOFFMANN-LA ROCHE AG
F. HOFFMANN-LA ROCHE AG – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emer…
- Risk and Resilience in Developmental Diversity and Mental Health Individuals with mental health (MH) conditions and their families, especially those with highly prevalent neu…
- Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future Enzyme catalysis is an essential technology at the heart of industrial biotechnology, expected to foster the…
- From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network Every year, around 600 children in the Netherlands get cancer and one in four children dies from this illness…
- Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer…
- CLinical impact through AI-assisted MS care Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system. Since there…
- GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal trea…
- Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract In the aging society, disease burden, such as degenerative diseases and cancer are rising while drug developm…